A randomized study of a flexible booster dosing regimen of VAQTA® in adults: safety, tolerability, and immunogenicity-Reference-Cited by-同舟云学术

A randomized study of a flexible booster dosing regimen of VAQTA® in adults: safety, tolerability, and immunogenicity

Published:2001-09 Issue:32 Volume:19 Page:4727-4731
ISSN:0264-410X
Container-title:Vaccine
language:en
Short-container-title:Vaccine

Author:

Hornick Richard,Tucker Richard,Kaplan Karen M.,Eves Karen A.,Banerjee Dalfoni,Jensen Erin,Kuter Barbara

Publisher

Elsevier BV

Subject

Infectious Diseases,Public Health, Environmental and Occupational Health,General Veterinary,General Immunology and Microbiology,Molecular Medicine

Reference7 articles.

1. Centers for Disease Control and Prevention. Prevention of hepatitis A through active or passive immunization: recommendations of the Advisory Committee on Immunization Practices (ACIP) 1999; 48 (RR-12): 1–38.

2. VAQTA® [package insert]. West Point, PA: Merck & Co, Inc.; 2000.

3. Use of a live, attenuated hepatitis A vaccine to prepare a highly purified, formalin-inactivated hepatitis A vaccine;Lewis,1991

4. Safety and immunogenicity of a live attenuated hepatitis A virus vaccine in seronegative volunteers;Midthun;J. Infect. Dis.,1991

5. Safety and immunogenicity of an inactivated hepatitis A virus vaccine; inactivated hepatitis A vaccine;Ellerbeck,1991

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Using the power law model to predict the long-term persistence and duration of detectable hepatitis A antibody after receipt of hepatitis A vaccine (VAQTA™);Vaccine;2021-05

2. Current and future vaccine clinical research with the licensed 2-, 4-, and 9-valent VLP HPV vaccines: What's ongoing, what's needed?;Preventive Medicine;2021-03

3. Prevention of Hepatitis A Virus Infection in the United States: Recommendations of the Advisory Committee on Immunization Practices, 2020;MMWR. Recommendations and Reports;2020-07-03

4. Safety and immunogenicity of VAQTA® in children 12-to-23 months of age with and without administration of other US pediatric vaccines;Human Vaccines & Immunotherapeutics;2018-11-15

5. Antibody responses among adolescent females receiving the quadrivalent HPV vaccine series corresponding to standard or non-standard dosing intervals;Vaccine;2015-04